PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29048639-4	2017	However, melanoma cells with TGF-beta1-induced epithelial-to-mesenchymal transition (EMT) were more sensitive to dabrafenib treatment compared to the sensitivity noted in the non-TGF-beta1-induced EMT melanoma cells, suggesting that TGF-beta1-induced EMT was not associated with dabrafenib resistance.	dabrafenib	279-289	transforming growth factor beta 1	Homo sapiens	29-38	
29048639-4	2017	However, melanoma cells with TGF-beta1-induced epithelial-to-mesenchymal transition (EMT) were more sensitive to dabrafenib treatment compared to the sensitivity noted in the non-TGF-beta1-induced EMT melanoma cells, suggesting that TGF-beta1-induced EMT was not associated with dabrafenib resistance.	dabrafenib	113-123	transforming growth factor beta 1	Homo sapiens	29-38	
29048639-4	2017	However, melanoma cells with TGF-beta1-induced epithelial-to-mesenchymal transition (EMT) were more sensitive to dabrafenib treatment compared to the sensitivity noted in the non-TGF-beta1-induced EMT melanoma cells, suggesting that TGF-beta1-induced EMT was not associated with dabrafenib resistance.	dabrafenib	113-123	transforming growth factor beta 1	Homo sapiens	179-188	
29048639-4	2017	However, melanoma cells with TGF-beta1-induced epithelial-to-mesenchymal transition (EMT) were more sensitive to dabrafenib treatment compared to the sensitivity noted in the non-TGF-beta1-induced EMT melanoma cells, suggesting that TGF-beta1-induced EMT was not associated with dabrafenib resistance.	dabrafenib	113-123	transforming growth factor beta 1	Homo sapiens	179-188